Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends
XTalks
AUGUST 2, 2023
In September 2022, Roche acquired Good Therapeutics for an upfront payment of $250 million, and has access to their PD-1-regulated IL-2 program. The company also continued the implementation of some global restructuring plans started in previous years, as well as initiating a portfolio prioritization program for their Pharmaceutical division.
88 
Let's personalize your content